Abstract: Systems, devices, and techniques for performing wavelength division multiplexing or demultiplexing using one or more metamaterials in an optical communications systems are described. An optical device may be configured to shift one or more phase profiles of an optical signal using one or more stages of metamaterials to multiplex or demultiplex wavelengths of optical signals. The optical device may be an example of a stacked design with two or more stages of metamaterials stacked on top of one another. The optical device may be an example of a folded design that reflects optical signals between different stages of metamaterials.
Type:
Grant
Filed:
January 29, 2021
Date of Patent:
June 16, 2026
Assignees:
CORNING INCORPORATED, HARVARD COLLEGE
Inventors:
Federico Capasso, Wei-Ting Chen, Paulo Clovis Dainese, Jr., Kangmei Li, Ming-Jun Li, Jaewon Oh, Jun Yang
Abstract: Systems, devices, and techniques for performing wavelength division multiplexing or demultiplexing using one or more metamaterials in an optical communications systems are described. An optical device may be configured to shift one or more phase profiles of an optical signal using one or more stages of metamaterials to multiplex or demultiplex wavelengths of optical signals. The optical device may be an example of a stacked design with two or more stages of metamaterials stacked on top of one another. The optical device may be an example of a folded design that reflects optical signals between different stages of metamaterials.
Type:
Grant
Filed:
January 29, 2021
Date of Patent:
September 2, 2025
Assignees:
CORNING INCORPORATED, HARVARD COLLEGE
Inventors:
Federico Capasso, Wei-Ting Chen, Paulo Clovis Dainese, Jr., Kangmei Li, Ming-Jun Li, Jaewon Oh, Jun Yang
Abstract: Disclosed herein is a method for regulating the activity of NF-&kgr;B in an animal comprising contacting cells of the animal with certain proteasome inhibitors.
Type:
Application
Filed:
January 28, 2003
Publication date:
May 20, 2004
Applicant:
Harvard College
Inventors:
Vito J. Palombella, Alfred L. Goldberg, Thomas P. Maniatis, Oliver Rando
Abstract: A method for inhibiting or relaxing skeletal muscle contractions which comprises contacting said skeletal muscle with a skeletal muscle relaxing amount, and a method for the treatment of disease states resulting from or exacerbated by undesirable contractions of skeletal muscle, which comprises administering a skeletal muscle relaxing amount to an individual in need thereof of a compound selected from the group consisting of nitroxyl ion (NO.sup.-), nitrosonium ion (NO.sup.+), nitric oxide and nitric oxide adducts or providers. This invention also is directed to stimulating the contraction of muscles in a mammal by administering an effective amount of a nitric oxide synthase inhibitor.
Abstract: A method for inhibiting or relaxing skeletal muscle contractions and for treating disease states resulting from or exacerbated by undesirable skeletal muscle contractions by administering a skeletal muscle relaxing amount of nitroxyl ion(NO.sup.-), nitrosonium ion(NO.sup.+), nitric oxide and nitric oxide adducts or providers. A process for stimulating, improving or enhancing muscle contraction in a mammal by treating the mammal with an effective amount of (i) a nitric oxide synthase inhibitor or (ii) a nitric oxide scavenger.